Skip to main content
. 2016 May 5;114(12):1343–1351. doi: 10.1038/bjc.2016.113

Figure 4.

Figure 4

CCR6–CCL20 interaction inhibits proliferation of colon cancer cells. (A) BrDU incorporation assay was used to determine proliferation in untreated (open box) and CCL20-treated (solid box) colon cancer cells. Significant (***P-value<0.001 and **P-value<0.01) differences in proliferation rate of CCL20-treated cells compared with the untreated cells are shown. (B) Percentage decrease in proliferation of colon cancer cells after CCL20 treatment compared with untreated cells. Significant (**P-value<0.00001, ***P-value<0.000001 and ****P-value<0.0000001) decrease in proliferation of CCL20-treated cells compared with untreated cells is shown.